Gut microbially produced tryptophan metabolite melatonin ameliorates osteoporosis via modulating SCFA and TMAO metabolism
Journal of Pineal Research · 2024-04 · 76 (3)
DOI: 10.1111/jpi.12954 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Pineal Research, online erschienen am 15.04.2024. Verfasst von Yueqi Chen und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedics, Southwest Hospital, Third Military Medical University, Chongqing, China. Hauptthemen laut MEDLINE: Melatonin. Die Arbeit wurde bisher 62-mal zitiert (Crossref) und nennt 109 Literaturangaben. Gefördert von: Outstanding postgraduate tutor team building project, Key Clinical Specialty of PLA, Excellent Talent projects from the AMU.
Abstract (Originalsprache)
Osteoporosis (OP) is a severe global health issue that has significant implications for productivity and human lifespan. Gut microbiota dysbiosis has been demonstrated to be closely associated with OP progression. Melatonin (MLT) is an important endogenous hormone that modulates bone metabolism, maintains bone homeostasis, and improves OP progression. Multiple studies indicated that MLT participates in the regulation of intestinal microbiota and gut barrier function. However, the promising effects of gut microbiota‐derived MLT in OP remain unclear. Here, we found that OP resulted in intestinal tryptophan disorder and decreased the production of gut microbiota‐derived MLT, while administration with MLT could mitigate OP‐related clinical symptoms and reverse gut microbiota dysbiosis, including the diversity of intestinal microbiota, the relative abundance of many probiotics such as Allobaculum and Parasutterella , and metabolic function of intestinal flora such as amino acid metabolism, nucleotide metabolism, and energy metabolism. Notably, MLT significantly increased the production of short‐chain fatty acids and decreased trimethylamine N‐oxide‐related metabolites. Importantly, MLT could modulate the dynamic balance of M1/M2 macrophages, reduce the serum levels of pro‐inflammatory cytokines, and restore gut‐barrier function. Taken together, our results highlighted the important roles of gut microbially derived MLT in OP progression via the “gut‐bone” axis associated with SCFA metabolism, which may provide novel insight into the development of MLT as a promising drug for treating OP.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Orthopedics, Southwest Hospital, Third Military Medical University, Chongqing, China.
- Department of Orthopedics, Chinese PLA 76th Army Corps Hospital, Beijing, Xining, China.
- Department of Biomedical Materials Science, Third Military Medical University, Chongqing, China.
- Department of Dermatology, Air Force Medical Center, Fourth Military Medical University, Beijing, China.
Förderung
- Outstanding postgraduate tutor team building project
- Key Clinical Specialty of PLA
- Excellent Talent projects from the AMU
- Chongqing Academic Research Leader project
Zitieren
APA
Chen, Y., Yang, C., Deng, Z., Xiang, T., Ni, Q., Xu, J., Sun, D., & Luo, F. (2024). Gut microbially produced tryptophan metabolite melatonin ameliorates osteoporosis via modulating SCFA and TMAO metabolism. Journal of Pineal Research, 76(3). https://doi.org/10.1111/jpi.12954
Vancouver
Chen Y, Yang C, Deng Z, Xiang T, Ni Q, Xu J, et al. Gut microbially produced tryptophan metabolite melatonin ameliorates osteoporosis via modulating SCFA and TMAO metabolism. Journal of Pineal Research. 2024;76(3). doi:10.1111/jpi.12954
BibTeX
@article{Chen2024,
author = {Chen, Yueqi and Yang, Chuan and Deng, Zihan and Xiang, Tingwen and Ni, Qingrong and Xu, Jianzhong and Sun, Dong and Luo, Fei},
title = {Gut microbially produced tryptophan metabolite melatonin ameliorates osteoporosis via modulating SCFA and TMAO metabolism},
journal = {Journal of Pineal Research},
year = {2024},
volume = {76},
number = {3},
doi = {10.1111/jpi.12954}
}
EUVIMED